Navigating The Leadership Void: CBER Turnover, Staff Retention, And The Future of OTP
Source: Advancing RNA
In this Advancing RNA Live clip, regulatory experts Daniela Drago and Tiffany Lucas discuss the latest turnover of leadership at CBER and within the Office of Therapeutic Products (OTP).
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA